rExenatide-4 (Shijiazhuang Zhongqi Pharmaceutical)
重组胰高血糖素样肽-1受体激动剂（石药集团中奇制药技术）
Report date: 2022/01/14 13:23:58
Base Information
Drug NamerExenatide-4 (Shijiazhuang Zhongqi Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A